While the stock of Johnson & Johnson (JNJ) has the same value it had ten years ago, the company has doubled sales and increased earnings per share 116% over the same time period. Perhaps more importantly, they have increased their dividend by 221%, boosting it every year; the stock now yields 3.5%.
The stock has traded very tightly since December 2011 and looks ready to clear resistance in the 66 area. The healthcare sector also looks strong recently on a relative strength basis.
A riskier way to play JNJ is with call options. The deep-in-the-money January 19, 2013 50-strike call options have hardly any premium in them and offer a leveraged way to participate in JNJ price appreciation, albeit with no dividends.